Literature DB >> 11263939

Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report.

A Koul1, N Loman, S Malander, A Borg , M Ridderheim.   

Abstract

BACKGROUND: Cerebral metastasis secondary to ovarian cancer is a rare phenomenon. While no clear relationship to known prognostic factors is found, others suggest this as a biologically diverse behavior of ovarian cancer. CASES: In a pilot study, 37 invasive epithelial ovarian cancer samples were analyzed to detect the frequency of BRCA1/BRCA2 mutations in the south of Sweden (results published). A retrospective follow-up revealed that 2 of these (2/37; 5.4%) patients developed central nervous system metastases during the course of their disease. Both patients had advanced surgical stage disease at the time of diagnosis, with histopathological serous type tumors that were negative for estrogen and progesterone receptors. One of these patients carried a germline BRCA1 mutation, whereas a somatic BRCA1 mutation was identified in the other patient.
CONCLUSIONS: To the best of our knowledge the molecular genetic profile of these tumors is not found in the literature and it is suggested that such analyses could provide some insight for a better understanding of this rare phenomenon. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11263939     DOI: 10.1006/gyno.2000.6085

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases.

Authors:  Giancarlo D'Andrea; Raffaelino Roperto; Lavinia Dinia; Emanuela Caroli; Maurizio Salvati; Luigi Ferrante
Journal:  Neurosurg Rev       Date:  2004-11-19       Impact factor: 3.042

2.  A late, solitary brain metastasis of epithelial ovarian carcinoma.

Authors:  Raffaele Longo; Christian Platini; Nada Eid; Clémence Elias-Matta; Thaar Buda; Denis 'Nguyen; Philippe Quétin
Journal:  BMC Cancer       Date:  2014-07-28       Impact factor: 4.430

3.  Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations.

Authors:  S Balendran; S Liebmann-Reindl; A S Berghoff; T Reischer; N Popitsch; C B Geier; L Kenner; P Birner; B Streubel; M Preusser
Journal:  J Neurooncol       Date:  2017-05-11       Impact factor: 4.130

Review 4.  miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition.

Authors:  Siti A Sulaiman; Nurul-Syakima Ab Mutalib; Rahman Jamal
Journal:  Front Pharmacol       Date:  2016-08-23       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.